HK Stock MarketDetailed Quotes

02196 FOSUN PHARMA

Watchlist
  • 14.560
  • +0.060+0.41%
Market Closed Dec 12 16:08 CST
38.80BMarket Cap16.45P/E (TTM)

FOSUN PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

FOSUN PHARMA FY2024 9-Month Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
30.91B
--
+0.69%
EPS
--
0.75
--
-11.76%
Analyst Rating
Hold

Dec 12, 2024

FOSUN PHARMA Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.266B--
--2024/Q4-- / 10.839B--
Oct 29, 20242024/Q3-- / 10.338B--
Aug 27, 20242024/Q2-- / 10.561B--
Apr 29, 20242024/Q1-- / 10.691B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.266B--
--2024/Q4-- / 10.839B--
Oct 29, 20242024/Q3-- / 10.338B--
Aug 27, 20242024/Q2-- / 10.561B--
Apr 29, 20242024/Q1-- / 10.691B--

Unlock Free Earnings Estimates

FOSUN PHARMA Earnings Reports

  • FOSUN PHARMA: 2024 THIRD QUARTERLY REPORT

    Oct 29 07:34 ET

  • FOSUN PHARMA: DATE OF BOARD MEETING

    Oct 17 04:30 ET

  • FOSUN PHARMA: Interim Report 2024

    Sep 20 04:43 ET

  • FOSUN PHARMA: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024 AND CHANGE OF JOINT COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE

    Aug 27 10:32 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 12, 2024

    Hold

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      100.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Aesthetic Medicine
    Aesthetic Medicine
    Intraday+2.67%